Indoco wins two awards at the Pharmexcil Awards function held at Secunderabad recently. Indoco has bagged these two prestigious awards in the area of 'Intellectual Property (Patents)' and 'Export Performance'. The award was received at the hands of minister for Commerce and Industry, Government of India, Anand Sharma. Dubbed as a special honour in the pharmaceutical industry, these awards recognise Indoco's expertise in the coveted areas of research & development and international business.
Commenting on the awards, Suresh G Kare, chairman and managing director, Indoco Remedies Limited, said, "This is a momentous occasion for team Indoco. It gives us immense pleasure and satisfaction on winning the Pharmexcil awards. These awards show that Indoco is on the right path, in the right areas and is set for a giant leap ahead in the international arena with innovative products backed by belligerent strategies. We thank Pharmexcil for acknowledging Indoco's work."
The Pharmexcil Patent Award signifies the importance of innovation, uniqueness of the pharmaceutical concept, efficacy & allied benefits derived from the patents. Indoco's three patents in the areas of 'Controlled drug delivery system for gastric-retentive floating dosage forms', 'A stable dermatological composition' and 'A novel synergistic pharmaceutical composition' were selected by eminent jury members, experts in the area of Intellectual Property, for Indoco's nomination for this prestigious award.
Indoco has been consistently registering growth year after year in exports to over 30 countries. The success story began in 2003 with approval of Indoco's manufacturing facility by UK-MHRA and today the international business from Finished Dosages alone has crossed the Rs 1000 million mark. The exports of APIs, Intermediates and (R&D) services are also contributing significantly. This achievement was recognised by Pharmexcil and Indoco was selected for the 'Pharmexcil Export Award' in the General Category.
Established in the year 1947, Indoco Remedies is a global pharmaceutical company with a presence across continents in 35 countries.
Under the able leadership of Suresh G Kare, chairman and managing director, Indoco Remedies has scaled newer heights and is now a USD 100 million turnover organization employing about 3000 people. Indoco has a strong brand portfolio of 120 products in various therapeutic segments, including high growth life style segments such as anti-infectives, anti-diabetics, cardiovascular, opthal, dental care, pain management and respiratory. Top Indoco brands include Cyclopam, Vepan, Febrex Plus, ATM, Sensodent - K, Sensoform.
Indoco has Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) manufacturing facilties in Goa, Baddi, Waluj, Navi Mumbai and Patalganga in India. Indoco also has a state-of-the-art research centre at Navi Mumbai with over 100 scientists. With approval of its Finished Dosage facilities by the US - FDA, Darmstadt - Germany, TGA Australia, MCC-South Africa and UK - MHRA, Indoco Remedies has emerged as the most suitable partner and provider of Contract Research and Manufacturing Services (CRAMS) to its customers globally.
Indoco Remedies Limited shares were listed in 2005 on BSE and NSE.